Literature DB >> 16915372

Eosinophilic tumor in a patient with bronchial asthma receiving pranlukast.

Toru Watanabe1, Yasufumi Iinuma, Shin-ichi Naito, Koju Nitta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915372     DOI: 10.1007/s00431-006-0226-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  7 in total

1.  The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report.

Authors:  P F Weller; M Plaut; V Taggart; A Trontell
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

2.  Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast.

Authors:  M E Wechsler; E Garpestad; S R Flier; O Kocher; D A Weiland; A J Polito; M M Klinek; T D Bigby; G A Wong; R A Helmers; J M Drazen
Journal:  JAMA       Date:  1998-02-11       Impact factor: 56.272

3.  Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.

Authors:  M Hashimoto; T Fujishima; H Tanaka; H Kon; T Saikai; A Suzuki; M Nakatsugawa; S Abe
Journal:  Intern Med       Date:  2001-05       Impact factor: 1.271

Review 4.  Churg-Strauss syndrome in two patients receiving montelukast.

Authors:  P Guilpain; J-F Viallard; P Lagarde; P Cohen; M Kambouchner; J-L Pellegrin; L Guillevin
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

Review 5.  Churg-Strauss syndrome.

Authors:  Imre Noth; Mary E Strek; Alan R Leff
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

Review 6.  Leukotriene antagonists and the Churg-Strauss syndrome.

Authors:  Ghassan Jamaleddine; Karim Diab; Zuhayr Tabbarah; Ayman Tawil; Thurayya Arayssi
Journal:  Semin Arthritis Rheum       Date:  2002-02       Impact factor: 5.532

Review 7.  Pranlukast: a review of its use in the management of asthma.

Authors:  Susan J Keam; Katherine A Lyseng-Williamson; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.